Integrating Recent Evidence on Microbial Virulence and Host Immune Dysregulation in Diabetic Foot Ulcers: Chronicity Mechanisms and Therapeutic Advances
Anjali Pandey, Shikha yadav, Shatrudhan Prajapati, Rohit DasIntroduction:
Diabetic Foot Ulcers (DFUs) are among the most devastating complications of diabetes mellitus and are associated with chronic non-healing wounds, recurrent infections, hospitalization, and lower-limb amputation. Multiple factors contribute to DFU pathogenesis, including chronic hyperglycemia, vascular impairment, neuropathy, immune dysfunction, and bacterial overgrowth. Recent evidence highlights the important roles of microbial virulence factors and dysregulated host immune responses in chronic inflammation and impaired wound healing.
Methods:
This review examines recent literature on DFU chronicity, microbial ecology, virulence mechanisms, immune dysfunction, and molecular pathways associated with chronic wound development. Particular emphasis is placed on the interactions between pathogenic microorganisms and host immune responses, including biofilm formation, oxidative stress, cytokine dysregulation, and impaired cellular functions. Recent diagnostic approaches and emerging therapeutic strategies were also evaluated.
Results:
Biofilm formation, toxin production, and antimicrobial resistance contribute substantially to the persistence of chronic DFU infections, which are commonly associated with polymicrobial communities including Staphylococcus aureus, Pseudomonas aeruginosa, Enterobacteriaceae, and anaerobic bacteria. Diabetes-associated immune dysfunction, including impaired neutrophil activity, altered macrophage polarization, T-cell dysfunction, and persistent inflammatory cytokine production, further compromises wound healing. Advances in molecular diagnostics, microbiome analysis, and biomarker-guided approaches have improved understanding of DFU pathophysiology. Emerging therapies, including antimicrobial peptides, bacteriophage therapy, stem cell-based therapies, immunomodulatory strategies, and smart biomaterials, show promising potential.
Discussion:
Current evidence indicates that microbial virulence and host immune dysfunction interact to perpetuate chronic inflammation and delayed wound healing in DFUs. Biofilm formation, persistent infection, impaired immune responses, and cytokine imbalance contribute to wound chronicity and therapeutic resistance. Advances in molecular diagnostics and emerging therapeutic approaches may facilitate more personalized management and improved healing outcomes.
Conclusion:
DFU chronicity is driven by a complex bidirectional interaction between microbial factors and host immune dysfunction. Further investigation of these interactions may support the development of precision-based therapeutic strategies to improve wound healing, reduce complications, and decrease the risk of amputation in patients with diabetes.